|

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

RECRUITINGSponsored by M.D. Anderson Cancer Center
Actively Recruiting
SponsorM.D. Anderson Cancer Center
Started2019-04-08
Est. completion2027-02-02
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05108519

Summary

This study collects information about complications and clinical response in cancer patients treated with anti-VEGF-related therapies. This study aims to observe side effects that may happen to patients with advanced cancer who are treated with anti-VEGF related therapy. This may help doctors learn if there are any relationships between these side effects and how the disease may respond to treatment.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients must be able to understand and be willing to sign a written informed consent document
* Patients must be receiving any anti-VEGF-related regimen in monotherapy or combination therapy

Conditions3

CancerHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Locations1 site

M D Anderson Cancer Center
Houston, Texas, 77030
Nicolas L. Palaskas713-563-3532nlpalaskas@mdanderson.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.